Moor Matthias B相关文献与解析，生知库 | 链接生命科学的每一步

Moor Matthias B, Burmakin Mikhail, Levin Anna, Korkut GÃ¼l Gizem, Brodin David, Wernerson Annika, Bruchfeld Annette, BÃ¡rÃ¡ny Peter, Witasp Anna, Patrakka Jaakko, Olauson Hannes

炎症/感染

FGF2

Immunology/Inflammation

炎症

发表日期：2026

文献求助收藏

Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial

恩格列净治疗非糖尿病钙结石和尿酸结石患者：一项随机 II 期试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-024-03330-x

Anderegg, Manuel A; Schietzel, Simeon; Bargagli, Matteo; Bally, Lia; Faller, Nicolas; Moor, Matthias B; Cereghetti, Grazia M; Roumet, Marie; Trelle, Sven; Fuster, Daniel G

Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study

德国5岁以下儿童接种BNT162b2 mRNA新冠疫苗（CoVacU5）后症状的性别差异：一项回顾性队列研究

期刊:Biology of Sex Differences

影响因子:5.1

doi:10.1186/s13293-024-00651-x

Moor, Jeanne; Toepfner, Nicole; von Meißner, Wolfgang C G; Berner, Reinhard; Moor, Matthias B; Kublickiene, Karolina; Strumann, Christoph; Chao, Cho-Ming

Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation

阐明人类肾移植中缺血再灌注损伤和远程缺血预处理的分子反应

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0311613

Nordström, Johan; Badia-I-Mompel, Pau; Witasp, Anna; Schwarz, Angelina; Evenepoel, Pieter; Moor, Matthias B; Wennberg, Lars; Saez-Rodriguez, Julio; Wernerson, Annika; Olauson, Hannes

发表日期：2024

文献求助收藏

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?

阿哌沙班在血液透析中的给药——药物浓度监测能否减少争议？

期刊:BMC Nephrology

影响因子:2.4

doi:10.1186/s12882-024-03782-w

Schietzel, Simeon; Limacher, Andreas; Moor, Matthias B; Czerlau, Cecilia; Huynh-Do, Uyen; Vogt, Bruno; Aregger, Fabienne; Uehlinger, Dominik E

发表日期：2024

文献求助收藏

HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study

在已确诊皮肤疣和非黑色素瘤皮肤癌的免疫抑制患者中接种HPV疫苗：一项单中心队列研究

期刊:Vaccines

影响因子:3.4

doi:10.3390/vaccines11091490

Bossart, Simon; Daneluzzi, Cloé; Moor, Matthias B; Hirzel, Cédric; Heidemeyer, Kristine; Seyed Jafari, S Morteza; Hunger, Robert E; Sidler, Daniel

Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies - Authors' reply

B细胞耗竭后SARS-CoV-2疫苗的细胞反应：研究结果相互矛盾——作者回复

期刊:Lancet Rheumatology

影响因子:16.4

doi:10.1016/S2665-9913(22)00035-2

Moor, Matthias B; Suter-Riniker, Franziska; Hirzel, Cedric; Maurer, Britta; Sidler, Daniel

Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years

BNT162b2信使RNA新冠疫苗与其他已批准疫苗在5岁以下儿童中的安全性比较

期刊:Jama Network Open

影响因子:9.7

doi:10.1001/jamanetworkopen.2022.37140

Toepfner, Nicole; von Meißner, Wolfgang C G; Strumann, Christoph; Drinka, Denisa; Stuppe, David; Jorczyk, Maximilian; Moor, Jeanne; Püschel, Johannes; Liss, Melanie; von Poblotzki, Emilie; Berner, Reinhard; Moor, Matthias B; Chao, Cho-Ming

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

抗CD20疗法患者接种SARS-CoV-2疫苗后的体液和细胞免疫反应：一项纳入1342例患者的系统评价和荟萃分析

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2021-002036

Schietzel, Simeon; Anderegg, Manuel; Limacher, Andreas; Born, Alexander; Horn, Michael P; Maurer, Britta; Hirzel, Cedric; Sidler, Daniel; Moor, Matthias B

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

既往接受过抗CD20治疗的患者的体液免疫和细胞免疫轨迹以及对第三剂SARS-CoV-2 mRNA疫苗的反应。

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2021-002166

Sidler, Daniel; Born, Alexander; Schietzel, Simeon; Horn, Michael P; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Seyed Jafari, S Morteza; Radonjic-Hoesli, Susanne; Chan, Andrew; Hoepner, Robert; Bacher, Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Suter-Riniker, Franziska; Staehelin, Cornelia; Nagler, Michael; Hirzel, Cedric; Maurer, Britta; Moor, Matthias B

The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease.

在肾脏疾病中，肾脏对 FGF23 的反应从磷酸盐尿转变为炎症。

Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial

恩格列净治疗非糖尿病钙结石和尿酸结石患者：一项随机 II 期试验

Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study

德国5岁以下儿童接种BNT162b2 mRNA新冠疫苗（CoVacU5）后症状的性别差异：一项回顾性队列研究

Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation

阐明人类肾移植中缺血再灌注损伤和远程缺血预处理的分子反应

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?

阿哌沙班在血液透析中的给药——药物浓度监测能否减少争议？

HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study

在已确诊皮肤疣和非黑色素瘤皮肤癌的免疫抑制患者中接种HPV疫苗：一项单中心队列研究

Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies - Authors' reply

B细胞耗竭后SARS-CoV-2疫苗的细胞反应：研究结果相互矛盾——作者回复

Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years

BNT162b2信使RNA新冠疫苗与其他已批准疫苗在5岁以下儿童中的安全性比较

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

抗CD20疗法患者接种SARS-CoV-2疫苗后的体液和细胞免疫反应：一项纳入1342例患者的系统评价和荟萃分析

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

既往接受过抗CD20治疗的患者的体液免疫和细胞免疫轨迹以及对第三剂SARS-CoV-2 mRNA疫苗的反应。